Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016

Marandino, L. ; La Salvia, A. ; Sonetto, C. ; De Luca, E. ; Pignataro, D. ; Zichi, C. ; Di Stefano, R.F. ; Ghisoni, E. ; Lombardi, P. ; Mariniello, A. ; Reale, M.L. ; Trevisi, E. ; Leone, G. ; Muratori, L. ; Marcato, M. ; Bironzo, P. ; Novello, S. ; Aglietta, M. ; Scagliotti, G.V. ; Perrone, F. ; Di Maio, M.

England: Elsevier Ltd

Texto completo disponível

Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study

Bandini, M. ; Gibb, E.A. ; Gallina, A. ; Raggi, D. ; Marandino, L. ; Bianchi, M. ; Ross, J.S. ; Colecchia, M. ; Gandaglia, G. ; Fossati, N. ; Pederzoli, F. ; Lucianò, R. ; Colombo, R. ; Salonia, A. ; Briganti, A. ; Montorsi, F. ; Necchi, A.

England: Elsevier Ltd

Texto completo disponível

Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study

Giannatempo, P. ; Raggi, D. ; Marandino, L. ; Bandini, M. ; Farè, E. ; Calareso, G. ; Colecchia, M. ; Gallina, A. ; Ross, J.S. ; Alessi, A. ; Briganti, A. ; Montorsi, F. ; Madison, R. ; Necchi, A.

England: Elsevier Ltd

Texto completo disponível

Reply to the letter to the editor ‘On the underreporting of health-related quality of life and regulatory approval’ by Bhamidipati et al

Di Maio, M. ; Marandino, L. ; Perrone, F.

England: Elsevier Ltd

Texto completo disponível

674P Evaluation of cognitive function (CogF) in trials testing new-generation hormonal treatments (NGHT) in patients with prostate cancer (PC): A systematic review

Marandino, L. ; Buttigliero, C. ; Vignani, F. ; Gamba, T. ; Necchi, A. ; Tucci, M. ; Di Maio, M.

Elsevier Ltd

Texto completo disponível

1738P Three-year follow-up update and survival outcomes of the PURE-01 study

Padua, T.C.D. ; Basile, G. ; Bandini, M. ; Raggi, D. ; Marandino, L. ; Giannatempo, P. ; Colombo, R. ; Colecchia, M. ; Lucianò, R. ; Moschini, M. ; Briganti, A. ; Montorsi, F. ; Necchi, A.

Texto completo disponível

Chronic and late-onset toxicities from immune checkpoints inhibitors (ICIs): Analysis of the publications leading to ICIs approval between 2011 and 2019

Ghisoni, E. ; Marandino, L. ; Valabrega, G. ; Aglietta, M. ; Di Maio, M.

Texto completo disponível

Quality of life assessment and reporting in colorectal cancer: a systematic review of phase 3 trials published between 2012 and 2018

Lombardi, P. ; Marandino, L. ; De Luca, E. ; Zichi, C. ; Pignataro, D. ; Di Stefano, R. ; Ghisoni, E. ; Mariniello, A. ; Reale, M. ; Trevisi, E. ; Gianmarco, L. ; Muratori, L. ; La Salvia, A. ; Sonetto, C. ; Leone, F. ; Aglietta, M. ; Novello, S. ; Scagliotti, G. ; Perrone, F. ; Di Maio, M.

England: Elsevier Ltd

Texto completo disponível

773P Cabozantinib (CABO) plus durvalumab (DURVA) in patients (pts) with advanced urothelial carcinoma (UC) after platinum chemotherapy: Safety and preliminary activity of the open-label, single-arm, phase II ARCADIA trial

Marandino, L. ; Raggi, D. ; Giannatempo, P. ; Calareso, G. ; Alessi, A. ; Colecchia, M. ; Madison, R. ; Ross, J.S. ; Necchi, A.

Elsevier Ltd

Texto completo disponível

1626P Time trends (2012-2016 vs 2017-2021) in health-related quality of life (QoL) assessment and reporting in oncology: A systematic review of randomized phase III trials

Marandino, L. ; Trastu, F. ; Ghisoni, E. ; Lombardi, P. ; Mariniello, A. ; Reale, M.L. ; Aimar, G. ; Audisio, M. ; Bungaro, M. ; Caglio, A. ; Di Liello, R. ; Gamba, T. ; Gargiulo, P. ; Paratore, C. ; Rossi, A. ; Tuninetti, V. ; Turco, F. ; Perrone, F. ; Di Maio, M.

Texto completo disponível